Maha Othman: Students Bringing Biomedical Chemistry to Life Through a Mini Symposium
Maha Othman, Research Co-Lead at the CanVECTOR Research Network and Co-Chair of the SSC on Disseminated Intravascular Coagulation at the International Society on Thrombosis and Haemostasis (ISTH), shared a post on LinkedIn:
”Chemistry and biochemistry have always been among the more challenging university courses.
But when these disciplines are taught through the lens of Biomedical Chemistry and Laboratory Diagnostics, the complexity deepens-bridging foundational science with real clinical application.
And yet, my Year 2 BScN students St. Lawrence College rose to the challenge.
Through a Mini-Symposium, they brought this demanding science to life in a real-world, conference-style experience. Working in teams, they developed scientific posters translating complex biochemical concepts into meaningful clinical and laboratory insights—demonstrating how core science informs patient care.
A sincere thank you to Upper-year student course mentors Jordan Harry Jayan Anpalahan Makenna Marlow, guest Ty Conlin who served as judges, and to peers whose evaluations fostered collaboration, critical thinking, and engagement.
I am incredibly proud of these students. They showed not only strong scientific understanding, but also the confidence to communicate their work-an essential skill for future nursing professionals.
Hosted at the Innovation Hub on the Kingston campus, this event reflects St. Lawrence College commitment to experiential, student-centred learning, where students move beyond theory to application.
Moments like these remind us that when students are given the opportunity and mentored, they don’t just learn science-they live it, apply it, and elevate it.
Lovely to be featured at SLC Communication newsletter.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support